Literature DB >> 14769395

Relationship between CSF hypocretin levels and hypocretin neuronal loss.

Dmitry Gerashchenko1, Eric Murillo-Rodriguez, Ling Lin, Man Xu, Laura Hallett, Seiji Nishino, Emmanuel Mignot, Priyattam J Shiromani.   

Abstract

The sleep disorder narcolepsy may now be considered a neurodegenerative disease, as there is a massive reduction in the number of neurons containing the neuropeptide, hypocretin (HCRT). Most narcoleptic patients have low to negligible levels of HCRT in the cerebrospinal fluid (CSF), and such measurements serve as an important diagnostic tool. However, the relationship between HCRT neurons and HCRT levels in CSF in human narcoleptics is not known and cannot be directly assessed. To identify this relationship in the present study, the neurotoxin, hypocretin-2-saporin (HCRT2-SAP), was administered to the lateral hypothalamus (LH) to lesion HCRT neurons. CSF was extracted at circadian times (ZT) 0 (time of lights-on) or ZT8 at various intervals (2, 4, 6, 12, 21, 36, 60 days) after neurotoxin administration. Compared to animals given saline in the LH, rats with an average loss of 73% of HCRT neurons had a 50% decline in CSF HCRT levels on day 60. The decline in HCRT levels was evident by day 6 and there was no recovery or further decrease. The decline in HCRT was correlated with increased REM sleep. Lesioned rats that were kept awake for 6 h were not able to release HCRT to match the output of saline rats. As most human narcoleptics have more than 80% reduction of CSF HCRT, the results from this study lead us to conclude that in these patients, virtually all of the HCRT neurons might be lost. In those narcoleptics where CSF levels are within the normal range, it is possible that not all of the HCRT neurons are lost and that the surviving HCRT neurons might be increasing output of CSF HCRT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769395     DOI: 10.1016/S0014-4886(03)00388-1

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  32 in total

1.  Reduced hypocretin (orexin) levels in dementia with Lewy bodies.

Authors:  Stephanie Lessig; Kiren Ubhi; Douglas Galasko; Anthony Adame; Emiley Pham; Kelly Remidios; Michael Chang; Lawrence A Hansen; Eliezer Masliah
Journal:  Neuroreport       Date:  2010-08-04       Impact factor: 1.837

2.  Hypocretin-1 (orexin A) levels are normal in Huntington's disease.

Authors:  Christian R Baumann; Martin Hersberger; Claudio L Bassetti
Journal:  J Neurol       Date:  2006-04-05       Impact factor: 4.849

Review 3.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 4.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

5.  Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results.

Authors:  Oscar Arias-Carrión; Eric Murillo-Rodriguez; Man Xu; Carlos Blanco-Centurion; Rene Drucker-Colín; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

6.  A role for orexin in cytotoxic chemotherapy-induced fatigue.

Authors:  K B Weymann; L J Wood; X Zhu; D L Marks
Journal:  Brain Behav Immun       Date:  2013-11-09       Impact factor: 7.217

7.  Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats.

Authors:  Camille Planty; Corey P Mallett; Kevin Yim; Jorge C G Blanco; Marina Boukhvalova; Thomas March; Robbert van der Most; Eric Destexhe
Journal:  Hum Vaccin Immunother       Date:  2016-09-14       Impact factor: 3.452

8.  Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Francesca Poli; Christian Franceschini; Antonia Parmeggiani; Piero Pirazzoli; Filippo Bernardi; Emmanuel Mignot; Alessandro Cicognani; Pasquale Montagna
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

9.  Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.

Authors:  Andri Savvidou; Stine Knudsen; Mia Olsson-Engman; Steen Gammeltoft; Poul Jennum; Lars Palm
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

10.  Hypocretin and human African trypanosomiasis.

Authors:  Yves Dauvilliers; Sylvie Bisser; Florian Chapotot; Gedeao Vatunga; Raymond Cespuglio; Téofilo Josenando; Alain Buguet
Journal:  Sleep       Date:  2008-03       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.